共 142 条
[1]
Sorajja P(2003)Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease Circulation 108 2342-2348
[2]
Ommen SR(1996)Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study Eur Heart J 17 1056-1064
[3]
Nishimura RA(2020)Frequency and significance of coronary artery disease and myocardial bridging in patients with hypertrophic cardiomyopathy Am J Cardiol 125 1404-1412
[4]
Gersh BJ(1976)Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis Am J Cardiol 38 12-16
[5]
Berger PB(1992)Clinical significance of coronary artery disease in hypertrophic cardiomyopathy Am J Cardiol 70 499-501
[6]
Tajik AJ(2021)Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy BMC Cardiovasc Disord 21 556-244
[7]
Elliott PM(2018)Cardiac biomarkers: what is and what can be Indian J Cardiovasc Dis Women WINCARS 3 240-56
[8]
Kaski JC(2019)Biomarkers in routine heart failure clinical care Card Fail Rev 5 50-332
[9]
Prasad K(2022)Circulating biomarkers in hypertrophic cardiomyopathy J Am Heart Assoc 11 2974-151
[10]
Seo H(2022)Differential diagnosis between Takotsubo syndrome and acute coronary syndrome—a prospective analysis of novel cardiovascular biomarkers for a more selective triage J Clin Med 11 328-4602